2nd Invitation to Manufacturers of therapeutics against Ebola Virus Disease to submit an Expression of Interest (EOI) published
A second Invitation to Manufacturers of therapeutics against Ebola Virus Disease to submit an Expression of Interest (EOI) for Product Evaluation to the WHO Prequalification Unit is being published
Workshop with UNDP to enhance understanding the prequalification process
The United Nations Development Programme (UNDP) procures diagnostic tests for Global Fund-supported programmes and supports Member States in accessing high-quality in vitro diagnostics (IVDs), incl
HIV focused prequalification in vitro diagnostics workshop
The Prequalification-In Vitro Diagnostics (IVD) team were invited by the US President’s Emergency Plan for AIDS Relief (PEPFAR) to present an overview of the current prequalification process for in
In vitro diagnostics assessors meeting and training
The WHO In Vitro Diagnostics (IVD) Assessment team held a meeting and trained assessors from 2 to 5 May in Geneva, Switzerland.
Newly prequalified Active Pharmaceutical Ingredient (API)
Nirmatrelvir (WHOAPI-458) manufactured by Z